Geron Future Growth
Future criteria checks 5/6
Geron is forecast to grow earnings and revenue by 72.6% and 51.9% per annum respectively while EPS is expected to grow by 72.4% per annum.
Key information
72.6%
Earnings growth rate
72.4%
EPS growth rate
Biotechs earnings growth | 27.6% |
Revenue growth rate | 51.9% |
Future return on equity | n/a |
Analyst coverage | Good |
Last updated | 13 Dec 2024 |
Recent future growth updates
Recent updates
Geron: A Post Earnings And Funding Announcement Assessment
Nov 07Is Geron (NASDAQ:GERN) Using Too Much Debt?
Oct 28Geron's Rytelo Gains Traction Despite Competitive Pressures (Rating Upgrade)
Aug 12Geron: Probabilistic And Modest Estimate Of Pricing For A Likely Acquisition
Jul 31Does Geron (NASDAQ:GERN) Have A Healthy Balance Sheet?
Jul 12Geron: Innovative Rytelo Enters A Challenging MDS Market
Jun 08Why We Think Geron Corporation's (NASDAQ:GERN) CEO Compensation Is Not Excessive At All
May 03Geron: Advisory Nod Boosts Approval Odds, But Market Position Remains Hazy
Mar 15Geron Post 2023 Earnings - Gearing Up For Critical Imetelstat AdCom, PDUFA
Mar 05Is Geron (NASDAQ:GERN) A Risky Investment?
Aug 25Is Geron (NASDAQ:GERN) Using Debt Sensibly?
May 12An Intrinsic Calculation For Geron Corporation (NASDAQ:GERN) Suggests It's 46% Undervalued
Dec 20Geron: A Major Catalyst For Shareholders Arrives In January - At Last
Sep 16Is Geron Corporation (NASDAQ:GERN) Trading At A 49% Discount?
Sep 14Geron rises on narrower-than-expected Q2 loss
Aug 12Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 559 | 116 | 57 | 100 | 6 |
12/31/2025 | 303 | -46 | -93 | -85 | 8 |
12/31/2024 | 91 | -167 | -115 | -198 | 8 |
9/30/2024 | 29 | -201 | -216 | -216 | N/A |
6/30/2024 | 1 | -220 | -209 | -208 | N/A |
3/31/2024 | 1 | -201 | -185 | -184 | N/A |
12/31/2023 | 0 | -184 | -169 | -168 | N/A |
9/30/2023 | 0 | -175 | -163 | -162 | N/A |
6/30/2023 | 0 | -171 | -142 | -141 | N/A |
3/31/2023 | 0 | -150 | -141 | -140 | N/A |
12/31/2022 | 1 | -142 | -128 | -127 | N/A |
9/30/2022 | 2 | -131 | -115 | -114 | N/A |
6/30/2022 | 1 | -117 | -108 | -108 | N/A |
3/31/2022 | 1 | -118 | -97 | -97 | N/A |
12/31/2021 | 1 | -116 | -96 | -96 | N/A |
9/30/2021 | 0 | -108 | -86 | -86 | N/A |
6/30/2021 | 0 | -101 | -79 | -79 | N/A |
3/31/2021 | 0 | -87 | -73 | -73 | N/A |
12/31/2020 | 0 | -76 | -67 | -67 | N/A |
9/30/2020 | 0 | -81 | -65 | -64 | N/A |
6/30/2020 | 0 | -76 | -62 | -61 | N/A |
3/31/2020 | 0 | -75 | -58 | -57 | N/A |
12/31/2019 | 0 | -69 | -44 | -44 | N/A |
9/30/2019 | 1 | -47 | -37 | -36 | N/A |
6/30/2019 | 1 | -37 | -31 | -31 | N/A |
3/31/2019 | 1 | -30 | -26 | -26 | N/A |
12/31/2018 | 1 | -27 | -21 | -21 | N/A |
9/30/2018 | 1 | -27 | -22 | -22 | N/A |
6/30/2018 | 1 | -28 | N/A | -21 | N/A |
3/31/2018 | 1 | -28 | N/A | -21 | N/A |
12/31/2017 | 1 | -28 | N/A | -21 | N/A |
9/30/2017 | 1 | -29 | N/A | -17 | N/A |
6/30/2017 | 6 | -26 | N/A | -19 | N/A |
3/31/2017 | 6 | -28 | N/A | -20 | N/A |
12/31/2016 | 6 | -30 | N/A | -18 | N/A |
9/30/2016 | 6 | -30 | N/A | -23 | N/A |
6/30/2016 | 37 | 1 | N/A | -21 | N/A |
3/31/2016 | 37 | 1 | N/A | -22 | N/A |
12/31/2015 | 36 | 0 | N/A | -24 | N/A |
9/30/2015 | 36 | 0 | N/A | 10 | N/A |
6/30/2015 | 1 | -37 | N/A | 10 | N/A |
3/31/2015 | 1 | -37 | N/A | 11 | N/A |
12/31/2014 | 1 | -36 | N/A | 9 | N/A |
9/30/2014 | 1 | -36 | N/A | -26 | N/A |
6/30/2014 | 1 | -35 | N/A | -27 | N/A |
3/31/2014 | 1 | -35 | N/A | -30 | N/A |
12/31/2013 | 1 | -38 | N/A | -37 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: GERN is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.6%).
Earnings vs Market: GERN is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: GERN is expected to become profitable in the next 3 years.
Revenue vs Market: GERN's revenue (51.9% per year) is forecast to grow faster than the US market (9.2% per year).
High Growth Revenue: GERN's revenue (51.9% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if GERN's Return on Equity is forecast to be high in 3 years time
Discover growth companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/27 00:02 |
End of Day Share Price | 2024/12/27 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Geron Corporation is covered by 29 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Carter Gould | Barclays |
Peter Lawson | Barclays |
George Zavoico | B. Riley Securities, Inc. |